Intraoperative Electrical Stimulation to Improve Nerve Grafting Outcome
Intraoperative Brief Electrical Stimulation to Improve Cross-Face Nerve Grafting Outcomes
- Facial Paralysis
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- The Cleveland Clinic
- Enrolment target
- 20
- Started
- 1 March 2023
- Main results due
- 31 December 2026
- Study sites
- 1
- Registry updated
- 28 September 2026
Can you take part?
- Ages 18 years to 80 years.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: 1. Patients 18-80 years-old with unilateral facial paralysis who are candidates for two- stage CFNG smile reanimation surgery (i.e. CFNG-driven free gracilis muscle transfer (FGMT) or dual innervation FGMT). 2. Agree to participate in the study. Exclusion Criteria: 1. Bilateral facial paralysis 2. Age less than 18 years-old or older than 80 years-old 3. Comorbid medical condition preventing two-stage CFNG surgery
What this study is about
In the sponsor’s own words, from the registry.
A research study to find out if brief intraoperative electrical stimulation therapy improves nerve regeneration and smile outcomes following two-stage cross face nerve graft facial reanimation surgery.
Study sites(1)
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT06335719. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me